2013
DOI: 10.1007/s11192-013-1182-6
|View full text |Cite
|
Sign up to set email alerts
|

Collaboration in pharmaceutical research: exploration of country-level determinants

Abstract: Standard-Nutzungsbedingungen:Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Zwecken und zum Privatgebrauch gespeichert und kopiert werden.Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich machen, vertreiben oder anderweitig nutzen.Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, gelten abweichend von diesen Nutzungsbedingungen die in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
43
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 49 publications
(47 citation statements)
references
References 68 publications
(39 reference statements)
4
43
0
Order By: Relevance
“…As expected, the estimates for the mass indicators have a positive sign and are significant, which not only indicates that a higher number of publications in a specific country increases the likelihood of cooperation with other countries, but also corroborates that the global scientific collaboration networks exhibit a “Matthew effect” or “the rich get richer” phenomenon. We conclude that the scientific sizes of countries are positive determinants of international co‐publication, which is in line with other studies (Cassi, Morrison, and Rabellotti ; Plotnikova and Rake ). In addition, ln( rdres ) and EDL are also positive and statistically significant at p < 0.01, which indicates that the number of R&D researchers and the EDL of a country will have an important role in facilitating collaborations.…”
Section: Resultssupporting
confidence: 92%
See 3 more Smart Citations
“…As expected, the estimates for the mass indicators have a positive sign and are significant, which not only indicates that a higher number of publications in a specific country increases the likelihood of cooperation with other countries, but also corroborates that the global scientific collaboration networks exhibit a “Matthew effect” or “the rich get richer” phenomenon. We conclude that the scientific sizes of countries are positive determinants of international co‐publication, which is in line with other studies (Cassi, Morrison, and Rabellotti ; Plotnikova and Rake ). In addition, ln( rdres ) and EDL are also positive and statistically significant at p < 0.01, which indicates that the number of R&D researchers and the EDL of a country will have an important role in facilitating collaborations.…”
Section: Resultssupporting
confidence: 92%
“…This result is consistent with the internationalization of inventive activity (Picci ) and the globalization of technology (Montobbio and Sterzi ). However, Cassi, Morrison, and Rabellotti () and Plotnikova and Rake () point out that a common language does not promote collaboration intensity at the country level. Researchers tend to use their native language to discuss questions.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The studies can also help to establish a core list of publications and databases that can be used to support information provision [11], pharmaceutical care and pharmacy education [12]. Worldwide, there is a large number of published scientometric studies in pharmacy [3,11,[13][14][15][16][17][18][19][20][21][22][23][24][25][26]. Such studies have determined the growth of literature, patents and citations in particular locations, author collaborative patterns, most prolific journals, institution and country-wise productivity, and major themes of research productivity.…”
Section: Introductionmentioning
confidence: 99%